3rd generation glp 1 agonist GLP-1 Orals and Multi-Agonists: Advancing Next-Gen Weight Loss Therapies with Humanized Models Transforming obesity: The advancement of
Description
10.1080/19490976.2023.2274124 109 WangW.MeiA.QianH.LiD.XuH.ChenJ.et al (2023b)
The margin over Merck was only $170 million, but the growth gap was far wider: Lilly expanded at 44.7% while Merck managed 1.3%
The maximum recommended dose is 70 mg per day
For patients without coverage approval, brand-name GLP-1 medications cost $900 to $1,500 per month cash, making insurance-free compounded therapy substantially more affordable
FDA Food and Drug Administration
